SEC Form 4 · accession 0001181431-15-007656
DAVITA INC. · DVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael David Staffieri
Officer — COO, Kidney Care
Period of report
May 28, 2015
Accepted (ET)
May 29, 2015 · 7:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000927066
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 28, 2015 | M | 35,000 | $41.505 | A | 43,215 | D | |
| Common Stock | May 28, 2015 | F | 17,282 | $84.06 | D | 25,933 | D | |
| Common StockF1 | May 28, 2015 | S | 9,050 | $84.0673 | D | 16,833 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF2 | $41.505 | May 28, 2015 | M | 35,000 | D | Mar 29, 2014 | Mar 29, 2016 | Common Stock | 35,000 | 40,000 | D |
Explanation of responses
- F1Represents the weighted average sale price of $84.0673. The range of prices for the sale of these shares was $84.05 - $84.11, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F2Stock Appreciation Rights granted on 3/29/2011, which vested 50% each on 3/29/2014 and 3/29/2015.